|
1
|
Hou W and Zhu X: Extra vascular
interventional treatment of liver cancer, present and future. Drug
Discov Ther. 9:335–341. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu LT, Zhou ZH, Lin JH, Chen Z, Wang K,
Wang P, Zhu XY, Shen YH, Meng ZQ and Liu LM: Clinical study of
transarterial chemoembolization combined with 3-dimensional
conformal radiotherapy for hepatocellular carcinoma. Eur J Surg
Oncol. 37:245–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kurokohchi K, Watanabe S, Masaki T, Hosomi
N, Miyauchi Y, Himoto T, Kimura Y, Nakai S, Deguchi A, Yoneyama H,
et al: Comparison between combination therapy of percutaneous
ethanol injection and radiofrequency ablation and radiofrequency
ablation alone for patients with hepatocellular carcinoma. World J
Gastroenterol. 11:1426–1432. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mulier S, Ni Y, Jamart J, Ruers T, Marchal
G and Michel L: Local recurrence after hepatic radiofrequency
coagulation: Multivariate meta-analysis and review of contributing
factors. Ann Surg. 242:158–171. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jarnagin WR: Management of small
hepatocellular carcinoma: A review of transplantation, resection,
and ablation. Ann Surg Oncol. 17:1226–1233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim JW, Shin SS, Heo SH, Hong JH, Lim HS,
Seon HJ, Hur YH, Park CH, Jeong YY and Kang HK: Ultrasound-guided
percutaneous radiofrequency ablation of liver tumors: how we do it
safely and completely. Korean J Radiol. 16:1226–1239. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang TT, Luo HC, Cui X, Zhang W, Zhang
LY, Chen XP and Li KY: Ultrasound-guided percutaneous microwave
ablation treatment of initial recurrent hepatocellular carcinoma
after hepatic resection: long-term outcomes. Ultrasound Med Biol.
41:2391–2399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Clark TW: Chemical ablation of liver
cancer. Tech Vasc Interv Radiol. 10:58–63. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sugiura Y, Iwasaka T and Tarumi N:
Percutaneous ethanol injection therapy: A new treatment for
hepatocellular carcinoma. Radiaology. 90:53–57. 1983.
|
|
10
|
Livraghi T, Giorgio A, Marin G, Salmi A,
de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S and
Torzilli G: Hepatocellular carcinoma and cirrhosis in 746 patients:
Long-term results of percutaneous ethanol injection. Radiology.
197:101–108. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rossi S, Di Stasi M, Buscarini E, Cavanna
L, Quaretti P, Squassante E, Garbagnati F and Buscarini L:
Percutaneous radiofrequency interstitial thermal ablation in the
treatment of small hepatocellular carcinoma. Cancer J Sci Am.
1:73–81. 1995.PubMed/NCBI
|
|
12
|
Kudo M: Radiofrequency ablation for
hepatocellular carcinoma: Updated review in 2010. Oncology.
78(Suppl 1): 113–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wahl DR, Stenmark MH, Tao Y, Pollom EL,
Caoili EM, Lawrence TS, Schipper MJ and Feng M: Outcomes After
Stereotactic Body Radiotherapy or Radiofrequency Ablation for
Hepatocellular Carcinoma. J Clin Oncol. Nov 30–2015.(Epub ahead of
print). PubMed/NCBI
|
|
14
|
Kai L, Jia L, Zhi-Gang W and Lei Y:
Ultrasonic guided percutaneous ethanol injection with or without
combined radiofrequency ablation for hepatocellular carcinomas.
Indian J Cancer. 52(Suppl): E102–E104. 2015.PubMed/NCBI
|
|
15
|
Rehman J, Landman J, Lee D, Venkatesh R,
Bostwick DG, Sundaram C and Clayman RV: Needle-based ablation of
renal parenchyma using microwave, cryoablation, impedance- and
temperature-based monopolar and bipolar radiofrequency, and liquid
and gel chemoablation: laboratory studies and review of the
literature. J Endourol. 18:83–104. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ogasawara S, Chiba T, Ooka Y, Suzuki E,
Kanogawa N, Saito T, Motoyama T, Tawada A, Kanai F and Yokosuka O:
Post-progression survival in patients with advanced hepatocellular
carcinoma resistant to sorafenib. Invest New Drugs. 14:1–3.
2016.
|
|
17
|
Shi F, Tan Z, An H, Wang X, Xu Y and Wang
S: Hepatocellular carcinoma ≤4 cm treated with radiofrequency
ablation with or without percutaneous ethanol injection. Ann
Hepatol. 15:61–70. 2015.2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu Y, Zhao X, Yun Q, Zhu X, Zhu Y, Li Q,
Hu K, Wang J and Qiao Z: Transarterial chemoembolization (TACE)
plus percutaneous ethanol injection (PEI) for the treatment of
unresectable hepatocellular carcinoma: A meta-analysis of
randomized controlled trials. Int J Clin Exp Med. 8:10388–10400.
2015.PubMed/NCBI
|
|
19
|
Yang B, Zan RY, Wang SY, Li XL, Wei ML,
Guo WH, You X, Li J and Liao ZY: Radiofrequency ablation versus
percutaneous ethanol injection for hepatocellular carcinoma: a
meta-analysis of randomized controlled trials. World J Surg Oncol.
13:962015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang H, Liang P, Yu XL, Cheng ZG, Han ZY,
Yu J and Liu FY: Safety assessment and therapeutic efficacy of
percutaneous microwave ablation therapy combined with percutaneous
ethanol injection for hepatocellular carcinoma adjacent to the
gallbladder. Int J Hyperthermia. 31:40–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
